India Chambers USA has appointed NutrifyToday cofounder Dr. Anand Swaroop as Country Representative (USA) and Head of its USA Desk to build a high-velocity corridor between India and the United States in responsible nutrition.
The new industry interface will be housed at NutrifyToday’s office in Somerset, New Jersey. It will operate as an open venue for leaders from both countries to meet, negotiate partnerships, and run technical workstreams, according to a media release.
The mandate reflects a maturing industry ambition: move beyond raw material exports and incremental category growth to a mainstream, outcome-driven preventive health sector powered by science, standardized quality, and cross-border commercialization.
Dr. Swaroop, long recognized for advancing science-first nutraceutical development in the U.S., will use the Somerset office as a convening hub for C-suite roundtables, regulator-ready documentation sprints, and joint R&D sessions.
According to NutrifyToday, the India Chambers USA Desk will focus on practical, time-bound initiatives that convert intent into market outcomes.
READ: WHO sets the record straight on autism after Trump’s remarks (
These include an R&D highway in responsible nutrition by establishing joint working groups linking U.S. brand R&D teams, Indian clinical sites, and method development labs to accelerate evidence-backed formulations in metabolic, cognitive, women’s health, and healthy aging.
Provide transparent access to India’s organic land bank by creating a digital “data room” that maps certified acreage, wild-harvest zones, and seasonality—giving U.S. buyers visibility on traceability, volumes, and harvest windows for active nutraceutical ingredients (ANI).
Policy and standards harmonization by aligning supplier practices with U.S. expectations on quality systems, labelling, and new ingredient pathways; translate those requirements into supplier playbooks and audit-readiness toolkits for Indian MSMEs.
Investment channelling by convening U.S. and Indian investors to co-fund dual-market innovations—pairing India-grown ANI and Ayurveda formulations with U.S. clinical endpoints and delivery technologies.
Startup exchange across incubation hubs with launch of a two-way “Nutra Startup Bridge” to provide soft-landing services, lab access, and mentors for young companies on both shores.
Ayurveda remains India’s strategic differentiator, but the emphasis is shifting from tradition to testable outcomes, according to the release. The Desk will encourage joint clinical programs, and real-world evidence designs for classic actives (ashwagandha, turmeric, boswellia, bacopa) and polyherbal constructs that mirror Ayurvedic practice. It will also spotlight frontier work, such as the AI-driven phytopharma evolution.
Dr. Swaroop argues that with AI, biotech, and a deeper research lens on Ayurveda, the supplements category can evolve into a mainstream, measurable, preventive health industry.
READ: Buying health insurance after arriving in the US: What Indian visitors should know (
That means building products and portfolios around endpoints—glycaemic control, stress biomarkers, sleep quality, mobility—not just ingredients or historical claims.
It also means investing in study design, data transparency, and post-market surveillance so that “responsible nutrition” is more than a slogan—it’s a standard.
The India Chambers USA Desk will operate on an “open door” model from NutrifyToday’s Somerset, NJ office, with scheduled industry days for U.S. and Indian stakeholders, sector-specific roundtables (e.g., sports nutrition, women’s health, healthy ageing), and confidential bilateral sessions for dealmaking.
The Desk will coordinate closely with Indian and U.S. incubators, trade bodies, and clinical networks to keep projects moving between lab, line, and launch.
For years, India supplied the world’s botanicals while others built global brands on top. The creation of a U.S.-based Desk under a science-led operator signals a new phase: co-development at speed, with shared standards and shared value.
If the model works, supplements won’t just grow by inches—they’ll scale as part of a broader, evidence-anchored preventive health economy, with India and the United States building the highway together, according to the release.